Lucentis - Roche and NICE see eye to eye after a price cut

The extent of the price cut in Lucentis is unknown, as it is covered by a confidentiality agreement between pharma companies and the government. But Roche has confirmed that a new lower price will apply to the drug in both wet AMD and DMO.

http://www.pharmafile.com/news/176562/new-price-and-data-changes-nice-view-lucentis?

Anyone know the price cut?

Source: PharmaGossip - January 4, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs